Astellas Pharma Stock News

The world class Irritable Bowel Syndrome (IBS) Market report studies extensive evaluation of the market growth predictions and restrictions. The strategies range from new product launches, expansions, agreements, joint ventures, partnerships, to acquisitions. This report comprises of a deep knowledge

An On-Demand Webinar supported by Astellas Pharma and developed in collaboration with the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA) just released. An On-Demand Webinar supported by Astellas Pharma and developed in collaboration with the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA) just released.

Complete study of the global Penicillin and Streptomycin market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of

Astellas Pharma Inc. (OTCMKTS:ALPMY) saw a large growth in short interest during the month of October. As of October 29th, there was short interest totalling 140,300 shares, a growth of 17.3% from the October 14th total of 119,600 shares. Based on an average daily volume of 95,000 shares, the short-interest ratio is presently 1.5 days. []

Significant business leaders are profiled in order to learn about the strategies utilized by profitable industries. To have a complete knowledge of the business, criteria such as technology, geography, and end-users are taken into consideration. This market research also examines

The global Cancer Vaccines market was valued at 4622.44 Million USD in 2020 and will grow with a CAGR of 13.89% from 2021 to 2027. Major factors driving market growth include an increase in the number of cancer patients, an

From November 10 until the end of the month, BKV Combinos are back on the road with their mustaches to encourage people to get screened for prostate cancer. The Budapest Public Transport Company (BKV) and the Budapest Transport Center (BKK) participated for the second time in the campaign, supported by Astellas Pharma, whose main goal [] The post Budapest Trams Raise Awareness of Mens Health with Mustaches appeared first on Hungary Today .

Japan's Ministry of Health, Labor, and Welfare (MHLW) has approved Astellas Pharma Inc's (OTC: ALPMF) Padcev (enfortumab vedotin) for radically unresectable urothelial carcinoma that has progress

Astellas Pharma, Inc. (ALPMF) Q1 2022 Results - Earnings Call Transcript

Cytokinetics Inc (NASDAQ: CYTK) revealed in an SEC filing that Astellas Pharma Inc (OTCMKTS: ALPMY) is walking away from a pact to research and develop skeletal sarcomere activators for diseases

Astellas Pharma, Inc. (ALPMF) CEO Kenji Yasukawa on Q4 2021 Results - Earnings Call Transcript

In a financial notice posted earlier today, Astellas Pharma Inc (OTCMKTS: ALPMY) said it was taking an impairment loss of ¥58.8 billion ($540 million) because of last year's FDA clinical hold on Au

Astellas Pharma Plc (OTCMKTS: ALPMY) has reported positive topline results from two Phase 3 trials, SKYLIGHT 1 and SKYLIGHT 2, evaluating an oral non-hormonal compound, fezolinetant, for treating m